International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future
- PMID: 32803012
- PMCID: PMC7419131
- DOI: 10.15167/2421-4248/jpmh2020.61.2.1244
International epidemiology of liver cancer: geographical distribution, secular trends and predicting the future
Abstract
Background: Liver cancer (LC) is ranked seventh common cancer in terms of the incidence; and the fourth in terms of the mortality of cancer in the world. The aim of this study was to investigate the international distribution of the incidence and mortality of LC in 2018 based on various socio-economic and political divisions in the world.
Material and methods: This study was conducted through the use of the incidence and mortality cancer data from GLOBOCAN Project in 2018. The Age-Standardized Incidence Rate (ASIR) and Age Standardized Mortality Rate (ASMR) of LC were expressed per 100,000 people. In the current report, we used Pearson correlation method to assess the correlation between ASIR and ASMR. Statistical significance was considered to be P < 0.05.
Results: The highest ASIR and ASMR of LC occurred in Asia (ASIR = 11.4 and ASMR = 10.5), and Western Pacific Region of the World Health Organization (ASIR = 17.4 and ASMR = 15.8), and those regions with income level equal to upper middle income (ASIR = 13.4 and ASMR = 6.6). Furthermore, the lowest ASIR and ASMR of LC occurred in in Latin America and Caribbean (ASIR = 5) and Europe (ASMR = 4.4), the South-East Asia region (ASIR = 4.5 and ASMR = 4.3), and regions with Low middle income (ASIR = 5.7) and regions with high income (ASMR = 2.7).
Conclusions: LC is one of the most important cancer forms in the world in terms of incidence and mortality. It is important to prevent exposure to known risk factors for LC by increasing the level of knowledge and attitudes of the community and prevent of morbidity and mortality of the population with early diagnosis and treatment of patients.
Keywords: Incidence; Liver Cancer; Mortality; The world; Trend.
©2020 Pacini Editore srl, Pisa, Italy.
Conflict of interest statement
Conflict of interest statement The authors declare no conflict of interest.
Figures
References
-
- Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, Allen C, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2018;4:1553-68. https://doi.org/10.1001/jamaoncol.2018.2706 10.1001/jamaoncol.2018.2706 - DOI - PMC - PubMed
-
- Alsayyad J, Hamadeh R. Cancer incidence among the Bahraini population: a five-year (1998-2002) experience. Ann Saudi Med 2007;27:251-8. https://doi.org/10.5144/0256-4947.2007.251 10.5144/0256-4947.2007.251 - DOI - PMC - PubMed
-
- Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. J BUON 2016;21:994-1004. - PubMed
-
- Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect 2016;7:360-72. https://doi.org/10.1016/j.phrp.2016.11.002 10.1016/j.phrp.2016.11.002 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical